A product liability lawsuit was filed in the U.S. District Court for the Southern District of Ohio by the widow of an Ohio man, who claims the use of Onglyza was the reason for the congestive heart failure suffered by her husband before his death.
Onglyza cases are centralized as a part of MDL No. 2809, which is witnessing a steady rise in the number of lawsuits as expected since its establishment in February, in the U.S. District Court for the Eastern District of Kentucky under U.S. District Judge Karen K. Caldwell.
Bristol-Myers Squibb and AstraZeneca are the defendants named in the Onglyza litigation over its alleged link to congestive heart failure and other side effects. Plaintiffs hold them responsible for not providing adequate cardiovascular injury warnings despite having the knowledge.